Non-invasive Prenatal Diagnosis Symposium
Isolation of fetal nucleated red blood cells (fNRBC) from maternal blood has been a major goal for non-invasive prenatal diagnosis. This up and coming approach is based on nano-velcro and herringbone microfluidic technology for capturing fNRBC as early as 7 week of gestation and accessing the complete fetal nuclear genome. These advantages are in contrast to the invasive, amniotic karyotyping and array-based cytogenetic testing, and the serum-based, cell-free DNA analysis which still relies on invasive procedure for genetic confirmation. We are inviting academia, clinical colleagues, and interested participants to join us and take advantage of this focused conference.
Pleace: NTUH International Convention Center, Room 203.
No.2, Xuzhou Rd., Zhongzheng Dist., Taipei City 100, Taiwan. 02-7724-0109
Time: July 24th, 2013 (Wed) 6PM - 9PM
Registration: Please use email or telephone to reserve prior to the symposium.
Contact: Rebecca Lee, Tel: (02)8751-1888 ext. 242, email: rebecca@abnova.com
18:00 Check-in
18:30 Opening Remark
Wilber Huang, MD, President & CEO, Abnova
Moderator
Chih-Ping Chen, MD, Mackay Memorial Hospital, Division of Genetics,
Department of Obstetrics & Gynecology, Head
Dinner Reception Begin
19:00 Current Status of Prenatal Diagnosis
Wilber Huang, MD, President & CEO, Abnova
19:30 Isolation of Fetal Nucleated Red Blood Cells from Maternal Blood
Hann Wen Guan, PhD, Vice President R&D, Abnova
20:00 Clinical Applications of Fetal Nucleated Red Blood Cells
Hsian-Rong Tseng, PhD, Professor UCLA Department of Molecular & Pharmacology, Founder, Cytolumina
20:30 Discussion and Closing Remarks
Wilber Huang, MD, President & CEO, Abnova
21:00 Product Showcase
|
